“We are not denying that there is a problem, but just picking on one bug shows that the motives are unscientific,” said the director general of Indian Council of Medical Research Dr VM Katoch.
One of the scientists working on the study, Timothy Walsh, speaking exclusively to CNN-IBN said, “Unfortunately I think the Indian government has vested interests in playing down the importance of NDM-1, which I think is very regrettable.”
One won’t catch the bug by drinking water in Delhi, but there is a cause for concern. Bacteria carrying the gene that produces the NDM-1 enzyme are resistant to very powerful antibiotics. The study published in the Lancet Infectious Diseases Journal found the NDM-1 enzyme in eleven different types of bacteria in Delhi, including those that cause dysentery and cholera.
Public Health Foundation of India (PHFI) expert Dr R Lakshminarayan said, “The bigger issue here is that earlier it was only one type of bacteria with NDM1 gene, but now, it’s cholera etc bacteria as well, which basically means that we are losing the cheaper antibiotics that are available.”
The government has now announced a six month study and patients to the emergency wards at selected hospitals in the capital, like Safdarjung and RML Hospitals will be tested for resistance to this specific form of antibiotic. If the results are positive, water samples around the hospital areas will be tested for the NDM-1 enzyme.
What is needed is stricter use of antibiotics. In fact, after the first Lancet study, tracing the superbug back to the sub-continent the Indian government announced it that would work out a new antibiotic policy, expected later this year.
Mahesh (MGIT – ECE 3rd year)
Watch this video….